Clinical Trials
3
Active:1
Completed:0
Trial Phases
2 Phases
Phase 1:2
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (66.7%)Phase 3
1 (33.3%)Safety and Efficacy of ZVS203e in the Treatment of Retinitis Pigmentosa Caused by RHO Gene Mutation
- First Posted Date
- 2025-05-01
- Last Posted Date
- 2025-05-01
- Lead Sponsor
- Chigenovo Co., Ltd
- Target Recruit Count
- 18
- Registration Number
- NCT06952842
- Locations
- 🇨🇳
Peking University Third Hospital, Beijing, Beijing, China
Efficacy and Safety of ZVS101e in Patients With Bietti 's Crystalline Dystrophy
Phase 3
Recruiting
- Conditions
- Bietti Crystalline Corneoretinal DystrophyBietti Crystalline Dystrophy
- Interventions
- First Posted Date
- 2024-12-20
- Last Posted Date
- 2025-01-03
- Lead Sponsor
- Chigenovo Co., Ltd
- Target Recruit Count
- 62
- Registration Number
- NCT06743646
- Locations
- 🇨🇳
Peking University Third Hospital, Beijing, Beijing, China
🇨🇳Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, Guangdong, China
🇨🇳The First Affiliated Hospital of Harbin Medical University, Haerbin, Heilongjiang, China
Safety and Efficacy of ZVS101e in Patients With Bietti 's Crystalline Dystrophy
- First Posted Date
- 2023-04-27
- Last Posted Date
- 2024-08-28
- Lead Sponsor
- Chigenovo Co., Ltd
- Target Recruit Count
- 24
- Registration Number
- NCT05832684
- Locations
- 🇨🇳
Peking University Third Hospital, Beijing, Beijing, China
🇨🇳West China Hospital, Sichuan University, Chengdu, Sichuan, China
🇨🇳Tianjin Medical University Eye Hospital, Tianjin, Tianjin, China
News
No news found